Carol Karp
Algemeen Adviseur bij PROTHENA CORPORATION PLC
Vermogen: - $ op 31-05-2024
Actieve functies van Carol Karp
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| PROTHENA CORPORATION PLC | Algemeen Adviseur | 15-12-2016 | - |
| Rochester Christian University | Directeur/Bestuurslid | - | - |
Loopbaan van Carol Karp
Eerdere bekende functies van Carol Karp
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ESPERION THERAPEUTICS, INC. | Compliance Officer | 01-01-2013 | 01-01-2014 |
| Algemeen Adviseur | 01-01-2013 | 01-01-2014 | |
| Janssen Alzheimer Immunotherapy | Algemeen Adviseur | 01-01-2010 | 01-01-2013 |
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Algemeen Adviseur | - | 02-05-2011 |
| VIVUS, INC. | Corporate Officer/Principal | - | - |
| Powderject Technologies BV | Hoofd Techniek/Wetenschap/O&O | - | - |
Opleiding van Carol Karp
| Rochester Christian University | Undergraduate Degree |
| New York University | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 7 |
| Nederland | 2 |
| Ierland | 2 |
Operationeel
| General Counsel | 4 |
| Undergraduate Degree | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoraal
| Health Technology | 5 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| ESPERION THERAPEUTICS, INC. | Health Technology |
| PROTHENA CORPORATION PLC | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
VIVUS, Inc.
 VIVUS, Inc. Pharmaceuticals: MajorHealth Technology VIVUS, Inc. engaged in the development and commercialization of novel therapeutic products. The firm’s products were indicated for the treatment of obese and overweight patients, exocrine pancreatic insufficiency, and erectile dysfunction. Its products include PANCREAZE, Qsymia, and STENDRA/SPEDRA. The company was founded by Virgil A. Place in April 16, 1991 and it was headquartered in Campbell, CA. | Health Technology |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Health Technology |
| Powderject Technologies BV | |
| Janssen Alzheimer Immunotherapy |
- Beurs
- Insiders
- Carol Karp
- Ervaring
